# Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects

> **NCT05526690** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 27 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Metformin
- **DRUG:** CIN-107

## Key facts

- **NCT ID:** NCT05526690
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-28
- **Primary completion:** 2020-12-12
- **Final completion:** 2020-12-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05526690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05526690, "Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05526690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*